Fortis Healthcare Limited , a prominent player in the Indian healthcare sector, has achieved a significant milestone in its corporate restructuring efforts. The company recently received approval from the National Company Law Tribunals (NCLTs) of New Delhi and Chandigarh for a composite scheme of arrangement involving three of its wholly-owned subsidiaries.

Key Highlights of the Restructuring Scheme

• The scheme involves International Hospital Limited, Fortis Hospitals Limited, and Fortis Hospotel Limited.
• NCLT New Delhi approved the scheme on May 9, while NCLT Chandigarh approved it on July 30.
• The appointed date for the scheme is April 1, 2023.
• The restructuring aims to streamline the company's complex corporate structure and enhance operational efficiency.

Financial Overview of Involved Subsidiaries

The three subsidiaries involved in the restructuring operate in the healthcare sector and have a combined paid-up capital of INR 9,708.01 million and a total turnover of INR 50,298.26 million.

Rationale and Impact

The primary objective of this restructuring is to rationalize Fortis Healthcare's complex corporate group structure. This move is expected to:

• Foster commercial expediency
• Reduce administrative, operational, and financial inefficiencies
• Streamline operations across the group

Next Steps and Implementation

The scheme will become effective once the certified copy of the Chandigarh NCLT order is filed with the Registrar of Companies. Importantly, this restructuring will not impact the shareholding pattern of Fortis Healthcare Limited, the listed entity.

The arrangement includes specific share exchange ratios between the entities involved, ensuring a smooth transition in the corporate structure.

Fortis Healthcare's move to simplify its corporate structure is a strategic step towards improving overall operational efficiency. As the healthcare sector continues to evolve, such corporate restructuring efforts may position the company to better navigate future challenges and opportunities in the Indian healthcare landscape.

Fortis Healthcare Limited announced a significant expansion in its healthcare portfolio as its wholly-owned subsidiary, Fortis Hospotel Limited (FHTL), successfully completed the acquisition of Shrimann Superspecialty Hospital's entire business operations. The transaction, which includes the hospital land and adjacent property, was finalized on July 24, 2025, at 09:14 PM IST.

Acquisition Details

The completion of this acquisition marks a crucial milestone for Fortis Healthcare, following a series of strategic moves earlier in the year. The company had previously disclosed information about the transaction through intimations to the stock exchanges in February, March, and May 2025, detailing the definitive agreements for this significant acquisition.

Regulatory Compliance

In compliance with Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015, Fortis Healthcare Limited promptly informed the National Stock Exchange of India Ltd. and BSE Limited about the successful consummation of the transaction. The disclosure was made through an official letter signed by Satyendra Chauhan, the Company Secretary & Compliance Officer of Fortis Healthcare Limited.

Strategic Implications

This acquisition is expected to strengthen Fortis Healthcare's market position and expand its healthcare services portfolio. By incorporating Shrimann Superspecialty Hospital's operations and assets, Fortis is poised to enhance its capabilities in specialized medical care and potentially increase its market share in the region.

Looking Ahead

While specific financial details of the transaction were not disclosed in the announcement, the acquisition of an entire hospital operation, including land and property, suggests a significant investment by Fortis Healthcare. This move aligns with the company's growth strategy and may lead to expanded service offerings and increased patient capacity in the future.

Investors and stakeholders will likely be watching closely to see how this acquisition impacts Fortis Healthcare's operational performance and market presence in the coming quarters.